CE Description
The NIH Stroke Scale Training Program is designed to allow healthcare providers to return to the course after designated time intervals to refresh their skills and demonstrate their continued mastery of this tool by successfully assessing a series of test scenarios. Each of these test groups is equivalent in size and scope, but the scenarios in each test group are different in order to assure mastery of the scale over time. Once a test group is successfully completed, that series of test scenarios should not be repeated and you will be allowed to advance to the next test group. A CE certificate may be claimed only once per test group, however, the certificate may be printed as many times as needed. The date within the certificate will reflect the date the certificate was originally claimed and printed.
NIHSS Course Module Intervals
After passing Group A, you should wait 6 months before taking Group B
After passing Group B, you should wait 12 months before taking Group C
Each additional module thereafter will follow the same 12 month interval
Group A – Group B = 6 month interval
Group B – Group C = 12 month interval
Group C – Group D = 12 month interval
Group D – Group E = 12 month interval
Group E – Group F = 12 month interval
Target Audience
The target audiences for this program are emergency physicians, neurologists, nurses, clinical researchers and medical students.
The NIH Stroke Scale is a critical component of acute stroke assessment. The American Stroke Association, in conjunction with the American Academy of Neurology (AAN) and the National Institute of Neurological Disorders and Stroke (NINDS) has developed this CME/CE certified, online training program for healthcare professionals to learn or review how to administer the NIH Stroke Scale for acute stroke assessment.
Learning Objectives
At the completion of this online course, the learner will be able to:
• Identify and assess neurological deficits in stroke patients
• Understand the measurement scale for quantifying neurological deficits in stroke patients
• Consistently apply appropriate scores for neurological deficits in stroke patients
• Use the scale to assess changes in neurological deficits in stroke patients over time
• Use "Test Completion" certificates to document compliance - valid for up to one (1) year
Technical Requirements
Continuing Education Information
NIH Stroke Scale Online Training Course; Enduring Web Course
ORIGINAL RELEASE DATE: 08/23/2004
TERMINATION DATE: 03/30/2025
LAST REVIEW DATE: March 2022
ACCREDITATION TERMS: Joint Accreditation: 03/31/2022 – 03/30/2025
Joint Accreditation Statements
In support of improving patient care, this activity has been planned and implemented by The American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Heart Association designates this activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 2.00 hours of Category I credit for completing this program.
AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
ANCC Credit Designation Statement - Nurses
The maximum number of hours awarded for this CE activity is 2.00 contact hours.
Disclosure Policy
All persons in a position to control educational content of a CE activity provided by the American Heart Association must disclose to the audience all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The presence or absence of all financial relationships will be disclosed to the audience in activity materials. All unlabeled/unapproved uses of drugs or devices discussed will also be disclosed to the audience. All relevant financial relationships have been mitigated prior to the commencement of the activity.
